Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biocryst Pharma Inc
(NQ:
BCRX
)
5.270
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
424
Open
5.270
Bid (Size)
5.150 (1)
Ask (Size)
5.260 (6)
Prev. Close
5.270
Today's Range
5.270 - 5.270
52wk Range
4.030 - 8.960
Shares Outstanding
185,583,896
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why BioCryst Pharmaceuticals Vaulted Nearly 20% Higher on Monday
May 06, 2024
A better-than-expected first quarter and a goal of profitability and positive cash flow by the end of 2025 brought on a bit of a rally.
Via
The Motley Fool
BioCryst Pharmaceuticals 'Fantastic' Q1 Earnings Rides On Outstanding Orladeyo Performance
May 06, 2024
BioCryst's impressive first-quarter earnings report surpasses estimates. Sales surged to $92.8 million, primarily driven by Orladeyo revenue growth. With strong patient demand and strategic...
Via
Benzinga
Performance
YTD
-13.18%
-13.18%
1 Month
+14.32%
+14.32%
3 Month
+2.53%
+2.53%
6 Month
-11.13%
-11.13%
1 Year
-37.93%
-37.93%
More News
Read More
BioCryst Pharmaceuticals (BCRX) Q1 2024 Earnings Call Transcript
May 06, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day Session
May 06, 2024
Via
Benzinga
BCRX Stock Earnings: BioCryst Pharma Beats EPS, Beats Revenue for Q1 2024
May 06, 2024
Via
InvestorPlace
A Preview Of BioCryst Pharma's Earnings
February 23, 2024
Via
Benzinga
What's Going On With BioCryst Pharmaceuticals Stock?
January 08, 2024
Via
Benzinga
Where BioCryst Pharma Stands With Analysts
November 20, 2023
Via
Benzinga
Hidden Penny Gems: 7 Stocks With Triple-Digit Growth Prospects
March 01, 2024
Via
InvestorPlace
BioCryst Pharmaceuticals (BCRX) Q4 2023 Earnings Call Transcript
February 26, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
What's Going On With BioCryst Stock After Earnings?
February 26, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
February 26, 2024
Via
Benzinga
Li Auto Posts Q4 Earnings, Joins Teva Pharmaceutical And Other Big Stocks Moving Higher In Monday's Pre-Market Session
February 26, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
What 7 Analyst Ratings Have To Say About BioCryst Pharma
September 25, 2023
Via
Benzinga
Analyst Expectations for BioCryst Pharma's Future
May 04, 2023
Via
Benzinga
Earnings Scheduled For February 26, 2024
February 26, 2024
Via
Benzinga
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 08, 2024
Via
Benzinga
Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 06, 2023
Via
Benzinga
BioCryst Pharmaceuticals (BCRX) Q3 2023 Earnings Call Transcript
November 03, 2023
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Benzinga's Top Ratings Upgrades, Downgrades For September 18, 2023
September 18, 2023
Via
Benzinga
3 Magnificent Growth Stocks to Buy on the Dip
August 28, 2023
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023
August 04, 2023
Via
Benzinga
BioCryst Pharmaceuticals (BCRX) Q2 2023 Earnings Call Transcript
August 03, 2023
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2023
July 13, 2023
Via
Benzinga
BioCryst Pharmaceuticals (BCRX) Q1 2023 Earnings Call Transcript
May 03, 2023
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.